Abstract
Hepatocellular carcinoma (HCC), unlike most solid tumors, can be diagnosed noninvasively. We present a case that highlights an important clinical difference between two established guidelines: National Cancer Comprehensive Network (NCCN) and Barcelona-2000 EASL Conference (European Association for the Study of the Liver). Our patient had a large liver mass extending into the right atrium with elevation of the alpha-fetoprotein to 1,130 ng/mL. The radiographic and laboratory evidence is sufficient usingNCCN guidelines to initiate palliative treatment for HCC. The Barcelona-2000 EASL Conference guideline for noninvasive diagnosis is restricted to cirrhotic patients. Our patient did not have a history of chronic liver disease or active hepatitis, and a biopsy was performed that demonstrated breast cancer.
Original language | English |
---|---|
Pages (from-to) | 145-148 |
Number of pages | 4 |
Journal | Journal of Gastrointestinal Cancer |
Volume | 41 |
Issue number | 2 |
DOIs | |
State | Published - Jun 2010 |
Keywords
- AFP
- Breast cancer
- HCC
- Hepatocellular carcinoma
- Noninvasive diagnosis
ASJC Scopus subject areas
- Oncology
- Gastroenterology